Dowling & Yahnke LLC Edwards Lifesciences Corp Transaction History

Dowling & Yahnke LLC

$215 Million
Q3 2022

A detailed history of Dowling & Yahnke LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Dowling & Yahnke LLC holds 4,343 shares of EW stock, worth $294,281. This represents 0.17% of its overall portfolio holdings.

Number of Shares

4,343

Previous 4,265 1.83%

Holding current value

$294,281

Previous $406,000 11.58%

% of portfolio

0.17%

Previous 0.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$82.37 - $107.29 $6,424 - $8,368	78 Added 1.83%	4,343 $359,000
Q2 2022 Aug 10, 2022	SELL	$86.5 - $128.27 $8,304 - $12,313	-96 Reduced 2.2%	4,265 $406,000
Q1 2022 May 04, 2022	BUY	$101.96 - $128.34 $40,784 - $51,336	400 Added 10.1%	4,361 $513,000
Q4 2021 Feb 10, 2022	SELL	$106.37 - $130.68 $3,403 - $4,181	-32 Reduced 0.8%	3,961 $513,000
Q2 2021 Jul 21, 2021	SELL	$83.84 - $104.76 $12,995 - $16,237	-155 Reduced 3.74%	3,993 $414,000
Q1 2021 Apr 29, 2021	BUY	$78.68 - $90.67 $7,946 - $9,157	101 Added 2.5%	4,148 $347,000
Q4 2020 Jan 28, 2021	BUY	$71.69 - $91.23 $64,521 - $82,107	900 Added 28.6%	4,047 $369,000
Q3 2020 Oct 19, 2020	BUY	$67.19 - $87.44 $4,434 - $5,771	66 Added 2.14%	3,147 $251,000
Q2 2020 Jul 31, 2020	BUY	$57.54 - $76.95 $177,280 - $237,082	3,081 New	3,081 $213,000
Q1 2020 May 15, 2020	SELL	$52.41 - $81.0 $55,659 - $86,022	-1,062 Closed	0 $0
Q4 2019 Jan 27, 2020	SELL	$71.7 - $82.09 $573 - $656	-8 Reduced 0.75%	1,062 $248,000
Q3 2019 Oct 29, 2019	BUY	$61.55 - $75.43 $65,858 - $80,710	1,070 New	1,070 $235,000
Q1 2018 May 01, 2018	SELL	$37.19 - $47.45 $71,999 - $91,863	-1,936 Closed	0 $0
Q4 2017 Feb 02, 2018	BUY	$33.79 - $39.39 $65,417 - $76,259	1,936	1,936 $218,000

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dowling & Yahnke LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dowling & Yahnke LLC with notifications on news.

Account

Dowling & Yahnke LLC Edwards Lifesciences Corp Transaction History